Loading
Latest filing published 20 Aug 2026 for HEM파마. Read the official filing
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of 지요셉 in HEM파마, where the filings describe the role as chief executive. Between 5 November 2024 and 20 August 2026, the trades on record add up to 9 filings.
On the open market, the record shows 2 purchases and 4 sales. The totals exclude 6 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2026, the count stands at no purchases and 1 sale.
The latest filing, published on 20 August 2026, reports a transaction in HEM파마. The most recent open-market purchase was published on 8 November 2024, 709 days ago. Typically, a trade is published a median of 4 days after it takes place. That lag is the time during which only the insider knows about the trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations